1. ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL. (14th December 2017) Authors: Taiwo, Babafemi O; Zheng, Lu; Stefanescu, Andrei; Nyaku, Amesika; Bezins, Baiba; Wallis, Carole L; Godfrey, Catherine; Sax, Paul E; Acosta, Edward; Haas, David; Smith, Kimberly Y; Sha, Beverly; Van Dam, Cornelius; Gulick, Roy M Journal: Clinical infectious diseases Issue: Volume 66:Number 11(2018) Page Start: 1689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy. (30th April 2019) Authors: Gillman, Jason; Janulis, Patrick; Gulick, Roy; Wallis, Carole L; Berzins, Baiba; Bedimo, Roger; Smith, Kimberly; Aboud, Michael; Taiwo, Babafemi Journal: Journal of antimicrobial chemotherapy Issue: Volume 74:Number 8(2019) Page Start: 2365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings. (14th November 2019) Authors: Wallis, Carole L; Hughes, Michael D; Ritz, Justin; Viana, Raquel; de Jesus, Carlos Silva; Saravanan, Shanmugam; van Schalkwyk, Marije; Mngqibisa, Rosie; Salata, Robert; Mugyenyi, Peter; Hogg, Evelyn; Hovind, Laura; Wieclaw, Linda; Gross, Robert; Godfrey, Catherine; Collier, Ann C; Grinsztejn, Bea... Journal: Clinical infectious diseases Issue: Volume 71:Number 7(2020) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa. Issue 1 (March 2018) Authors: Penrose, Kerri J; Brumme, Chanson J; Scoulos-Hanson, Maritsa; Hamanishi, Kristen; Gordon, Kelley; Viana, Raquel V; Wallis, Carole L; Harrigan, P Richard; Mellors, John W; Parikh, Urvi M Journal: Antiviral chemistry & chemotherapy Issue: Volume 26:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High Asymptomatic Carriage With the Omicron Variant in South Africa. (30th March 2022) Authors: Garrett, Nigel; Tapley, Asa; Andriesen, Jessica; Seocharan, Ishen; Fisher, Leigh H; Bunts, Lisa; Espy, Nicole; Wallis, Carole L; Randhawa, April Kaur; Miner, Maurine D; Ketter, Nzeera; Yacovone, Margaret; Goga, Ameena; Huang, Yunda; Hural, John; Kotze, Philip; Bekker, Linda Gail; Gray, Glenda E; ... Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: e289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. Issue 1 (January 2015) Authors: Gross, Robert; Zheng, Lu; Rosa, Alberto La; Sun, Xin; Rosenkranz, Susan L; Cardoso, Sandra Wagner; Ssali, Francis; Camp, Rob; Godfrey, Catherine; Cohn, Susan E; Robbins, Gregory K; Chisada, Anthony; Wallis, Carole L; Reynolds, Nancy R; Lu, Darlene; Safren, Steven A; Hosey, Lara; Severe, Patrice; ... Journal: Lancet Issue: Volume 2:Issue 1(2015) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. Issue 6 (June 2016) Authors: La Rosa, Alberto M; Harrison, Linda J; Taiwo, Babafemi; Wallis, Carole L; Zheng, Lu; Kim, Peter; Kumarasamy, Nagalingeswaran; Hosseinipour, Mina C; Jarocki, Bernadette; Mellors, John W; Collier, Ann C Journal: Lancet Issue: Volume 3:Issue 6(2016) Page Start: e247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reply to Suthar et al. (11th October 2018) Authors: Wallis, Carole L; Godfrey, Catherine; Fitzgibbon, Joseph E; Mellors, John W Journal: Journal of infectious diseases Issue: Volume 219:Number 4(2019) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. Issue 9 (September 2019) Authors: Grinsztejn, Beatriz; Hughes, Michael D; Ritz, Justin; Salata, Robert; Mugyenyi, Peter; Hogg, Evelyn; Wieclaw, Linda; Gross, Robert; Godfrey, Catherine; Cardoso, Sandra W; Bukuru, Aggrey; Makanga, Mumbi; Faesen, Sharlaa; Mave, Vidya; Wangari Ndege, Beatrice; Nerette Fontain, Sandy; Samaneka, Wadza... Journal: Lancet Issue: Volume 6:Issue 9(2019) Page Start: e588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗